Conventional transgenes in which expression of mutated NPM1 was regulated by the human MRP8 promoter [87] and a knock-in model mimicking the human mutation in the mouse Npm1 [88] developed myeloproliferative disease only but no AML. Here, NPM1 is linked to myeloproliferative disorder.